Autophagy induction contributes to the resistance to methotrexate treatment in rheumatoid arthritis fibroblast-like synovial cells through high mobility group box chromosomal protein 1

Abstract

BackgroundRheumatoid arthritis fibroblast-like synovial cells (RA-FLS) show resistance to methotrexate (MTX) treatment. To better understand the mechanisms of this resistance, RA-FLS and osteoarthritis fibroblast-like synovial cells (OA-FLS) were isolated and exposed to MTX. We analyzed the autophagy induced by MTX in vitro and its relationship to apoptosis.MethodsCell viability was evaluated using a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay, and apoptosis was detected by flow cytometry and Western blot analysis. Autophagy was determined by transmission electron microscopy as well as Western blot analysis. The expression levels of Beclin-1, LC3, Akt, p-Akt, mammalian target of rapamycin (mTOR), p-mTOR, high mobility group box chromosomal protein 1 (HMGB1), and an 85 kDa caspase cleaved fragment of poly(ADP-ribose) polymerase were measured by Western blotting.ResultsMTX-induced apoptosis was increased in OA-FLS compared with RA-FLS. However, MTX stimulated the autophagy response in RA-FLS by inducing autophagosome formation, but not in OA-FLS. In RA-FLS, transfection with Beclin-1 small interfering RNA inhibited autophagy and increased susceptibility to MTX, which induces cell death. MTX upregulated autophagy through its ability to enhance the expression of HMGB1 and Beclin-1 rather than through the Akt/mTOR pathway.ConclusionsAutophagy induction contributes to resistance to MTX treatment in fibroblasts from patients with rheumatoid arthritis.Electronic supplementary materialThe online version of this article (doi:10.1186/s13075-015-0892-y) contains supplementary material, which is available to authorized users.

HMGB1-mediated autophagy decreases sensitivity to oxymatrine in SW982 human synovial sarcoma cells

“…Some of the mechanisms underlying drug resistance in various diseases have been established, such as DNA repair mechanisms, drug export transporters and resistance to apoptosis4041. Recent studies have found that autophagy is associated with drug resistance and that it protects cells from the cytotoxicity of chemotherapy drugs in many diseases, including cancer and inflammatory diseases3537. In our study, we found that the expression of LC3-II was increased by OMT treatment.…”

“…Thin sections (60 nm) were placed on 200 mesh copper standard grids and stained with uranyl acetate and lead citrate. The ultrastructure of the cells was observed with a H-7650 transmission electron microscope (HITACHI, Ibaraki, Japan)37.…”

Autophagy: controlling cell fate in rheumatic diseases

“…These RA FLS show signs of myofibroblast differentiation (an intermediate cell type between a smooth muscle cell and a fibroblast), such as increased collagen deposition and expression of αsmooth muscle actin, which contribute to syno vial fibrosis 97 . In RA FLS, multiple mechanisms confer resistance to programmed cell death, including increased levels of antiapoptotic factors, downregulation of proap optotic factors 98 and increased autophagy [99][100][101][102] . Ex vivo studies show that the rate of apoptosis in RA FLS has an inverse relationship to the expression of beclin1 and LC3 (REF.…”

Targeting the tumour stroma to improve cancer therapy

“…Chemotherapy cannot eliminate 100% of cancer cells partially due to intrinsic resistant phenotypes within the cancer cell population. Moreover, the tumour stroma can promote cancer cell survival and proliferation in a treatment-naïve setting and in response to treatment, which does not eliminate nonproliferating stromal cells 105 ; this intrinsic resistance might be at least partially the result of induction of autophagy rather than apoptosis in response to external agents 229 and enables stromal cells to divert their response to a nonlethal stress response.…”